Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company.

The combined company will have a large stable of household brands under one roof, putting Kenvue’s Listerine mouthwash and ...

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company. Shareholders of Kimberly-Clark will own about 54% of ...

Attorney General Ken Paxton files an acetaminophen lawsuit in Texas, aligning with Trump and RFK Jr. on autism. It’s political, designed to win an endorsement.

At first glance, Dollar Tree looks like it has some of the best deals on everyday essentials, but some “savings” don’t hold up under unit math. It may look like you’re getting a better price at Dollar ...

The consumer products giant reached a $40 billion deal to buy Kenvue, the maker of Tylenol, despite a barrage of unproven ...

The merger comes as the acetaminophen drug faces scrutiny from the Trump administration and a lawsuit from Texas.

Kenvue faces investor pressure amid strategic review, leadership changes and litigation risk Trump administration position on Tylenol erased $10 billion in market value Potential sale or spin-off of ...

Health Secretary Robert F. Kennedy, Jr. Thursday reasserted the unproven link between the pain reliever Tylenol and autism, and suggested people who opposed the theory were motivated by hatred for ...

President Trump warned that acetaminophen, the active ingredient in Tylenol, is a potential cause of autism. WSJ’s Brianna Abbott explains if science backs up the claim. Photo: Kevin ...